AIM ImmunoTech Inc (AIM)
0.2527
+0.01
(+4.42%)
USD |
NYAM |
Nov 14, 16:00
0.247
-0.01
(-2.26%)
After-Hours: 20:00
AIM ImmunoTech Cash and Short Term Investments (Quarterly): 10.06M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.06M |
| March 31, 2024 | 10.94M |
| December 31, 2023 | 13.07M |
| September 30, 2023 | 22.43M |
| June 30, 2023 | 28.40M |
| March 31, 2023 | 30.85M |
| December 31, 2022 | 34.19M |
| September 30, 2022 | 36.74M |
| June 30, 2022 | 41.77M |
| March 31, 2022 | 44.54M |
| December 31, 2021 | 48.27M |
| September 30, 2021 | 37.85M |
| June 30, 2021 | 41.14M |
| March 31, 2021 | 49.94M |
| December 31, 2020 | 39.00M |
| September 30, 2020 | 39.64M |
| June 30, 2020 | 35.00M |
| March 31, 2020 | 28.09M |
| December 31, 2019 | 8.778M |
| September 30, 2019 | 11.73M |
| June 30, 2019 | 2.864M |
| March 31, 2019 | 4.88M |
| December 31, 2018 | 1.825M |
| September 30, 2018 | 4.075M |
| June 30, 2018 | 4.242M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.639M |
| December 31, 2017 | 2.107M |
| September 30, 2017 | 2.303M |
| June 30, 2017 | 3.211M |
| March 31, 2017 | 3.749M |
| December 31, 2016 | 5.868M |
| September 30, 2016 | 8.009M |
| June 30, 2016 | 6.512M |
| March 31, 2016 | 7.849M |
| December 31, 2015 | 8.91M |
| September 30, 2015 | 12.38M |
| June 30, 2015 | 15.71M |
| March 31, 2015 | 17.00M |
| December 31, 2014 | 16.11M |
| September 30, 2014 | 17.43M |
| June 30, 2014 | 20.21M |
| March 31, 2014 | 21.55M |
| December 31, 2013 | 18.19M |
| September 30, 2013 | 29.22M |
| June 30, 2013 | 32.52M |
| March 31, 2013 | 37.84M |
| December 31, 2012 | 43.95M |
| September 30, 2012 | 35.40M |
| June 30, 2012 | 28.96M |
| March 31, 2012 | 32.19M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.778M
Minimum
Dec 2019
49.94M
Maximum
Mar 2021
31.62M
Average
35.00M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 292.87M |
| Protalix BioTherapeutics Inc | 45.03M |
| Electromed Inc | 16.08M |
| Xtant Medical Holdings Inc | 5.379M |
| Armata Pharmaceuticals Inc | 26.40M |